Phenyl salicylate
Product Quick Detail
- Minimum Order
- 1
- Packaging
- N/A
- Delivery
- 15 Days
Specifications
Product Name: Phenyl salicylate
Synonyms: 2-hydroxy-benzoicaciphenylester;2-Phenoxycarbonylphenol;Benzoicacid,2-hydroxy-,phenylester;Fenylester kyseliny salicylove;fenylesterkyselinysalicylove;Musol;Phenol salicylate;Salphenyl
CAS: 118-55-8
MF: C13H10O3
MW: 214.22
EINECS: 204-259-2
Product Categories: Aromatic Esters;Functional Materials;Liquid Crystals & Related Compounds;Phenyl Esters (Liquid Crystals);Building Blocks;C12 to C63;Carbonyl Compounds;Chemical
Synthesis;Esters;Liquid Crystals;Materials Science;Organic and Printed Electronics;Organic Building Blocks
********************************************************************************
mp 41-43 °C(lit.)
bp 172-173 °C12 mm Hg(lit.)
density 1.250g/cm3
FEMA 3960
Fp >230 °F
storage temp. room temp
solubility dioxane: 0.1 g/mL, clear, colorless
Merck 14,7310
BRN 393969
Stability: Light sensitive. Incompatible with strong oxidants. Flammable.
- Country:
- Business Type:
- Market:
- Founded Year:
- Address:
- Contact:wang zzlhin
Other products from y.uancheng.
Relate products of Phenyl salicylate
2-BROMO-1-PHENYL-PENTAN-1-ONE CAS 49851-31-2
Name: 2-BROMO-1-PHENYL-PENTAN-1-ONE CAS 49851-31-2 Purity: 99% Type: Pharmaceutical Intermediates Appearance: Yellow oil Function: Pharmaceutical industry: Used as an intermediate in drug synthesis. Organic synthesis intermediates are often used in the preparation of the active ...
Intermediate Species 2-BROMO-1-PHENYL-PENTAN-1-ONE CAS 49851-31-2
名称： 2-溴-1-苯基戊酮 CAS 49851-31-2 纯度：99％ 类型：医药中间体 外观：黄色油状物 功能： 医药工业：用作药物合成中间体。有机合成中间体常用于制备药物的有效成分。 ...
Manufacture High Quality with Safe Delivery in Stock 2-BROMO-1-PHENYL-PENTAN-1-ONE CAS 49851-31-2
Name: 2-BROMO-1-PHENYL-PENTAN-1-ONE CAS 49851-31-2 Purity: 99% Type: Pharmaceutical Intermediates Appearance: Yellow oil Function: Pharmaceutical industry: Used as an intermediate in drug synthesis. Organic synthesis intermediates are often used in the preparation of the active ...
